Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2026-02-26 @ 11:14 AM
Study NCT ID:
NCT03059160
Status:
UNKNOWN
Last Update Posted:
2017-02-23
First Post:
2017-02-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Open Label Trial of Triheptanoin (UX007) in Treatment of Rett Syndrome.
Sponsor:
Sheba Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
3027-16-SMC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |